Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Greg Harrison is an analyst at Scotiabank. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/25/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/21/2025 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | 20.3% | Greg Harrison51% | $300 → $338 | Maintains | Sector Outperform | Get Alert |
| 03/20/2025 | LQDA | Buy Now | Liquidia | $15.60 | 117.95% | Greg Harrison51% | $30 → $34 | Maintains | Sector Outperform | Get Alert |
| 03/10/2025 | BEAM | Buy Now | Beam Therapeutics | $23.23 | 72.19% | Greg Harrison51% | → $40 | Upgrade | Sector Perform → Sector Outperform | Get Alert |
| 03/03/2025 | RCKT | Buy Now | Rocket Pharmaceuticals | $8.33 | 524.26% | Greg Harrison51% | $51 → $52 | Maintains | Sector Outperform | Get Alert |
| 03/03/2025 | IRON | Buy Now | Disc Medicine | $52.79 | 42.07% | Greg Harrison51% | $73 → $75 | Maintains | Sector Outperform | Get Alert |
| 03/03/2025 | BEAM | Buy Now | Beam Therapeutics | $23.23 | 7.62% | Greg Harrison51% | $24 → $25 | Maintains | Sector Perform | Get Alert |
| 02/27/2025 | GERN | Buy Now | Geron | $1.70 | 135.29% | Greg Harrison51% | $6 → $4 | Maintains | Sector Outperform | Get Alert |
| 02/21/2025 | BBIO | Buy Now | BridgeBio Pharma | $36.78 | 41.36% | Greg Harrison51% | $49 → $52 | Maintains | Sector Outperform | Get Alert |
| 02/14/2025 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | 6.78% | Greg Harrison51% | $310 → $300 | Maintains | Sector Outperform | Get Alert |
| 02/12/2025 | TVTX | Buy Now | Travere Therapeutics | $21.05 | 52.02% | Greg Harrison51% | $27 → $32 | Maintains | Sector Outperform | Get Alert |
| 02/12/2025 | BBIO | Buy Now | BridgeBio Pharma | $36.78 | 33.21% | Greg Harrison51% | $48 → $49 | Maintains | Sector Outperform | Get Alert |
| 02/11/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.10 | -12.13% | Greg Harrison51% | $433 → $450 | Maintains | Sector Perform | Get Alert |
| 01/31/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.10 | -15.45% | Greg Harrison51% | $430 → $433 | Maintains | Sector Perform | Get Alert |
| 01/22/2025 | IRON | Buy Now | Disc Medicine | $52.79 | 38.28% | Greg Harrison51% | $70 → $73 | Maintains | Sector Outperform | Get Alert |
| 01/16/2025 | KROS | Buy Now | Keros Therapeutics | $11.29 | 263.15% | Greg Harrison51% | $44 → $41 | Maintains | Sector Outperform | Get Alert |
| 12/23/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.10 | -16.03% | Greg Harrison51% | $426 → $430 | Maintains | Sector Perform | Get Alert |
| 12/13/2024 | KROS | Buy Now | Keros Therapeutics | $11.29 | 289.73% | Greg Harrison51% | $77 → $44 | Maintains | Sector Outperform | Get Alert |
| 12/09/2024 | AGIO | Buy Now | Agios Pharmaceuticals | $30.50 | 145.9% | Greg Harrison51% | $53 → $75 | Maintains | Sector Outperform | Get Alert |
| 11/25/2024 | BBIO | Buy Now | BridgeBio Pharma | $36.78 | 30.49% | Greg Harrison51% | $45 → $48 | Maintains | Sector Outperform | Get Alert |
| 11/15/2024 | BBIO | Buy Now | BridgeBio Pharma | $36.78 | 22.33% | Greg Harrison51% | $44 → $45 | Maintains | Sector Outperform | Get Alert |
| 11/06/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $23.76 | 26.26% | Greg Harrison51% | $35 → $30 | Maintains | Sector Perform | Get Alert |
| 11/05/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.10 | -5.1% | Greg Harrison51% | $480 → $486 | Maintains | Sector Perform | Get Alert |
| 11/05/2024 | IRON | Buy Now | Disc Medicine | $52.79 | 32.6% | Greg Harrison51% | $62 → $70 | Maintains | Sector Outperform | Get Alert |
| 11/01/2024 | TVTX | Buy Now | Travere Therapeutics | $21.05 | 28.27% | Greg Harrison51% | $23 → $27 | Maintains | Sector Outperform | Get Alert |
| 11/01/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | 10.34% | Greg Harrison51% | $305 → $310 | Maintains | Sector Outperform | Get Alert |
| 11/01/2024 | AGIO | Buy Now | Agios Pharmaceuticals | $30.50 | 73.77% | Greg Harrison51% | $51 → $53 | Maintains | Sector Outperform | Get Alert |
| 10/16/2024 | IRON | Buy Now | Disc Medicine | $52.79 | 17.45% | Greg Harrison51% | → $62 | Initiates | → Sector Outperform | Get Alert |
| 10/16/2024 | TVTX | Buy Now | Travere Therapeutics | $21.05 | 9.26% | Greg Harrison51% | → $23 | Initiates | → Sector Outperform | Get Alert |
| 10/16/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.10 | -6.27% | Greg Harrison51% | → $480 | Initiates | → Sector Perform | Get Alert |
| 10/16/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $280.96 | 8.56% | Greg Harrison51% | → $305 | Initiates | → Sector Outperform | Get Alert |
| 10/16/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $23.76 | 47.31% | Greg Harrison51% | → $35 | Initiates | → Sector Perform | Get Alert |
| 10/16/2024 | VERA | Buy Now | Vera Therapeutics | $26.70 | 124.72% | Greg Harrison51% | → $60 | Initiates | → Sector Outperform | Get Alert |
| 10/16/2024 | KROS | Buy Now | Keros Therapeutics | $11.29 | 582.02% | Greg Harrison51% | → $77 | Initiates | → Sector Outperform | Get Alert |
| 10/16/2024 | EYPT | Buy Now | EyePoint Pharmaceuticals | $6.24 | 188.46% | Greg Harrison51% | → $18 | Initiates | → Sector Outperform | Get Alert |
| 10/16/2024 | BEAM | Buy Now | Beam Therapeutics | $23.23 | 3.31% | Greg Harrison51% | → $24 | Initiates | → Sector Perform | Get Alert |
| 10/16/2024 | AGIO | Buy Now | Agios Pharmaceuticals | $30.50 | 67.21% | Greg Harrison51% | → $51 | Initiates | → Sector Outperform | Get Alert |
| 10/16/2024 | LQDA | Buy Now | Liquidia | $15.60 | 92.31% | Greg Harrison51% | → $30 | Initiates | → Sector Outperform | Get Alert |
| 10/16/2024 | GERN | Buy Now | Geron | $1.70 | 252.94% | Greg Harrison51% | → $6 | Initiates | → Sector Outperform | Get Alert |
| 10/16/2024 | RCKT | Buy Now | Rocket Pharmaceuticals | $8.33 | 500.25% | Greg Harrison51% | → $50 | Initiates | → Sector Outperform | Get Alert |
| 10/16/2024 | OCUL | Buy Now | Ocular Therapeutix | $7.53 | 192.16% | Greg Harrison51% | → $22 | Initiates | → Sector Outperform | Get Alert |
| 10/16/2024 | BBIO | Buy Now | BridgeBio Pharma | $36.78 | 19.61% | Greg Harrison51% | → $44 | Initiates | → Sector Outperform | Get Alert |
| 10/09/2024 | TVTX | Buy Now | Travere Therapeutics | $21.05 | -4.99% | Greg Harrison51% | $18 → $20 | Maintains | Buy | Get Alert |
| 09/27/2024 | TVTX | Buy Now | Travere Therapeutics | $21.05 | -14.49% | Greg Harrison51% | $19 → $18 | Maintains | Buy | Get Alert |
| 09/12/2024 | KROS | Buy Now | Keros Therapeutics | $11.29 | 573.16% | Greg Harrison51% | $81 → $76 | Maintains | Buy | Get Alert |
| 09/06/2024 | TVTX | Buy Now | Travere Therapeutics | $21.05 | -9.74% | Greg Harrison51% | $18 → $19 | Maintains | Buy | Get Alert |
| 08/20/2024 | LQDA | Buy Now | Liquidia | $15.60 | 47.44% | Greg Harrison51% | $24 → $23 | Maintains | Buy | Get Alert |
| 08/08/2024 | EDIT | Buy Now | Editas Medicine | $1.31 | 1045.04% | Greg Harrison51% | $13 → $15 | Upgrade | Neutral → Buy | Get Alert |
| 08/01/2024 | UTHR | Buy Now | United Therapeutics | $316.73 | -11.6% | Greg Harrison51% | $303 → $280 | Maintains | Underperform | Get Alert |
| 12/21/2023 | LQDA | Buy Now | Liquidia | $15.60 | -3.85% | Greg Harrison51% | $13 → $15 | Maintains | Buy | Get Alert |
| 12/15/2023 | BEAM | Buy Now | Beam Therapeutics | $23.23 | 50.67% | Greg Harrison51% | → $35 | Downgrade | Buy → Neutral | Get Alert |
| 09/22/2023 | TVTX | Buy Now | Travere Therapeutics | $21.05 | 28.27% | Greg Harrison51% | $41 → $27 | Maintains | Buy | Get Alert |
| 07/26/2023 | KROS | Buy Now | Keros Therapeutics | $11.29 | 475.73% | Greg Harrison51% | → $65 | Initiates | → Buy | Get Alert |
| 06/13/2023 | NTLA | Buy Now | Intellia Therapeutics | $8.73 | 942.38% | Greg Harrison51% | $89 → $91 | Maintains | Buy | Get Alert |
| 05/02/2023 | TVTX | Buy Now | Travere Therapeutics | $21.05 | 85.27% | Greg Harrison51% | $52 → $39 | Maintains | Buy | Get Alert |
| 05/01/2023 | STOK | Buy Now | Stoke Therapeutics | $7.74 | 55.04% | Greg Harrison51% | $9 → $12 | Upgrade | Underperform → Neutral | Get Alert |
| 04/28/2023 | SGMO | Buy Now | Sangamo Therapeutics | $0.85 | 76.51% | Greg Harrison51% | $5 → $1.5 | Downgrade | Neutral → Underperform | Get Alert |
| 03/07/2023 | MLYS | Buy Now | Mineralys Therapeutics | $16.78 | 132.42% | Greg Harrison51% | → $39 | Initiates | → Buy | Get Alert |
| 12/23/2022 | RCKT | Buy Now | Rocket Pharmaceuticals | $8.33 | 320.17% | Greg Harrison51% | $38 → $35 | Maintains | Buy | Get Alert |
| 11/18/2022 | EDIT | Buy Now | Editas Medicine | $1.31 | 1045.04% | Greg Harrison51% | $18 → $15 | Maintains | Neutral | Get Alert |
| 11/08/2022 | OMER | Buy Now | Omeros | $9.16 | -67.25% | Greg Harrison51% | → $3 | Downgrade | Neutral → Underperform | Get Alert |
| 09/29/2022 | EDIT | Buy Now | Editas Medicine | $1.31 | 1274.05% | Greg Harrison51% | → $18 | Initiates | → Neutral | Get Alert |
| 09/29/2022 | SNTI | Buy Now | Senti Biosciences | $3.70 | 89.19% | Greg Harrison51% | → $70 | Initiates | → Buy | Get Alert |
| 09/12/2022 | NLTX | Buy Now | Neoleukin Therapeutics | — | — | Greg Harrison51% | → $20 | Downgrade | Buy → Underperform | Get Alert |
| 06/16/2022 | NTLA | Buy Now | Intellia Therapeutics | $8.73 | 701.83% | Greg Harrison51% | → $70 | Initiates | → Buy | Get Alert |
| 06/08/2022 | RDUS | Buy Now | Radius Health | $29.01 | -72.42% | Greg Harrison51% | → $8 | Upgrade | Underperform → Neutral | Get Alert |
| 06/08/2022 | ISEE | Buy Now | IVERIC bio | — | — | Greg Harrison51% | → $18 | Initiates | → Buy | Get Alert |
| 05/26/2022 | LQDA | Buy Now | Liquidia | $15.60 | -23.08% | Greg Harrison51% | → $12 | Initiates | → Buy | Get Alert |
| 05/23/2022 | ATHX | Buy Now | Athersys | — | — | Greg Harrison51% | $25 → $6.25 | Downgrade | Neutral → Underperform | Get Alert |
| 03/16/2022 | STOK | Buy Now | Stoke Therapeutics | $7.74 | 416.8% | Greg Harrison51% | $43 → $40 | Maintains | Buy | Get Alert |
| 03/16/2022 | S | Buy Now | SentinelOne | $20.18 | 167.56% | Greg Harrison51% | $67 → $54 | Maintains | Buy | Get Alert |
| 03/16/2022 | ATHX | Buy Now | Athersys | — | — | Greg Harrison51% | $31.25 → $25 | Maintains | Neutral | Get Alert |
| 03/14/2022 | NKTR | Buy Now | Nektar Therapeutics | $0.84 | 614.29% | Greg Harrison51% | $18 → $6 | Downgrade | Neutral → Underperform | Get Alert |
| 12/03/2021 | STOK | Buy Now | Stoke Therapeutics | $7.74 | 455.56% | Greg Harrison51% | → $43 | Initiates | → Buy | Get Alert |
| 12/03/2021 | AGIO | Buy Now | Agios Pharmaceuticals | $30.50 | 77.05% | Greg Harrison51% | → $54 | Initiates | → Buy | Get Alert |
| 11/19/2021 | ATHX | Buy Now | Athersys | — | — | Greg Harrison51% | → $31.25 | Downgrade | Buy → Neutral | Get Alert |
| 09/10/2021 | NKTR | Buy Now | Nektar Therapeutics | $0.84 | 2042.86% | Greg Harrison51% | → $18 | Initiates | → Neutral | Get Alert |
| 09/10/2021 | BEAM | Buy Now | Beam Therapeutics | $23.23 | 545.72% | Greg Harrison51% | → $150 | Initiates | → Buy | Get Alert |
| 06/25/2020 | RCKT | Buy Now | Rocket Pharmaceuticals | $8.33 | 308.17% | Greg Harrison51% | → $34 | Reinstates | → Buy | Get Alert |
| 06/25/2020 | ATHX | Buy Now | Athersys | — | — | Greg Harrison51% | → $125 | Initiates | → Buy | Get Alert |
| 03/16/2020 | NLTX | Buy Now | Neoleukin Therapeutics | — | — | Greg Harrison51% | → $360 | Initiates | → Buy | Get Alert |
| 09/17/2014 | NKTR | Buy Now | Nektar Therapeutics | $0.84 | 1209.52% | Greg Harrison51% | $10 → $11 | Maintains | Underperform | Get Alert |
| 11/13/2012 | NKTR | Buy Now | Nektar Therapeutics | $0.84 | 733.33% | Greg Harrison51% | $7.5 → $7 | Maintains | Underperform | Get Alert |
| 01/20/2012 | NKTR | Buy Now | Nektar Therapeutics | $0.84 | 614.29% | Greg Harrison51% | → $6 | Downgrade | Neutral → Underperform | Get Alert |
